Impact Capital Partners LLC acquired a new stake in Colgate-Palmolive (NYSE:CL – Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 3,377 shares of the company’s stock, valued at approximately $307,000.
Several other hedge funds also recently added to or reduced their stakes in the stock. HBK Sorce Advisory LLC raised its position in Colgate-Palmolive by 10.1% in the fourth quarter. HBK Sorce Advisory LLC now owns 11,129 shares of the company’s stock valued at $1,012,000 after purchasing an additional 1,017 shares during the period. Wintrust Investments LLC purchased a new position in Colgate-Palmolive in the fourth quarter valued at about $33,000. Vestcor Inc increased its position in shares of Colgate-Palmolive by 2.0% during the fourth quarter. Vestcor Inc now owns 292,067 shares of the company’s stock worth $26,552,000 after acquiring an additional 5,745 shares during the last quarter. Avantax Advisory Services Inc. increased its position in shares of Colgate-Palmolive by 6.4% during the fourth quarter. Avantax Advisory Services Inc. now owns 56,782 shares of the company’s stock worth $5,162,000 after acquiring an additional 3,427 shares during the last quarter. Finally, Essential Planning LLC. purchased a new stake in shares of Colgate-Palmolive during the fourth quarter worth about $2,901,000. 80.41% of the stock is owned by hedge funds and other institutional investors.
Colgate-Palmolive Stock Performance
Shares of CL stock opened at $90.41 on Friday. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40. The business has a 50 day moving average of $89.03 and a two-hundred day moving average of $94.93. Colgate-Palmolive has a 52 week low of $85.32 and a 52 week high of $109.30. The company has a market cap of $73.37 billion, a P/E ratio of 25.69, a PEG ratio of 4.20 and a beta of 0.40.
Analysts Set New Price Targets
A number of brokerages have recently issued reports on CL. Piper Sandler dropped their target price on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a research report on Monday, January 6th. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $101.00 target price on shares of Colgate-Palmolive in a research report on Wednesday, January 29th. Raymond James reaffirmed an “outperform” rating and set a $105.00 target price (down from $110.00) on shares of Colgate-Palmolive in a research report on Monday, February 3rd. Morgan Stanley dropped their target price on Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating on the stock in a research report on Monday, February 3rd. Finally, UBS Group dropped their target price on Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating on the stock in a research report on Monday, February 3rd. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and twelve have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $101.61.
Check Out Our Latest Research Report on Colgate-Palmolive
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Read More
- Five stocks we like better than Colgate-Palmolive
- Consumer Discretionary Stocks Explained
- 3 Undervalued Stocks You Can Buy at a Discount Now
- 5 Top Rated Dividend Stocks to Consider
- AMD Stock: Can the PC Refresh Cycle Spark a Rally?
- Best Stocks Under $10.00
- Micron Stock Spikes 7%—3 Key Catalysts Behind the Move
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.